4//SEC Filing
Brzeczko Albert W 4
Accession 0001104659-22-035551
CIK 0000786947other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:05 PM ET
Size
6.3 KB
Accession
0001104659-22-035551
Insider Transaction Report
Form 4
Brzeczko Albert W
VP Technical Affairs
Transactions
- Award
Restricted Stock Unit
2022-03-16+40,000→ 117,332 totalExercise: $0.01→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]Awarded under the Acura Pharmaceuticals Inc. 2021 Restricted Stock Unit Award Plan (the "Plan").
- [F2]Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
- [F3]100% of Restricted Stock Units vest on December 31, 2022 or earlier if Reporting Person's service as an employee of Issuer is terminated by Issuer without Cause (as defined in the Plan) or due to Reporting Person's death or Disability (as defined in the Plan) or a qualifying change of control occurs. Distributions in respect of vested Restricted Stock Units will be made in three equal installments on the first business day of each of January 2024, 2025, and 2026 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code.
- [F4]Not Applicable.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001455740
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:05 PM ET
- Size
- 6.3 KB